EUVIMEDEUVIMED entdecken
Open Access

Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors

Beatriz E Nielsen iD, Christopher P Ford iD

Science Advances · 22.11.2024 · 10 (47)

DOI: 10.1126/sciadv.adp6301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 22.11.2024. Verfasst von Beatriz E Nielsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Levodopa, Dopamine, Corpus Striatum, Receptor, Muscarinic M4. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dynamic equilibrium between dopamine and acetylcholine (ACh) is essential for striatal circuitry and motor function, as imbalances are associated with Parkinson’s disease (PD) and levodopa-induced dyskinesia (LID). Conventional theories posit that cholinergic signaling is pathologically elevated in PD as a result of increased ACh release, which contributes to motor deficits. However, using approaches to measure receptor-mediated signaling, we found that, rather than the predicted enhancement, the strength of cholinergic transmission at muscarinic M4 receptor synapses on direct pathway medium spiny neurons was decreased in dopamine-depleted mice. This adaptation was due to a reduced postsynaptic M4 receptor function, resulting from down-regulated receptors and downstream signaling. Restoring M4 transmission unexpectedly led to a partial alleviation of motor deficits and LID dyskinetic behavior, revealing an unexpected prokinetic effect in addition to the canonical antikinetic role of M4 receptors. These findings indicate that decreased M4 function differentially contributes to parkinsonian and LID pathophysiology, representing a promising target for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaDopamineCorpus StriatumReceptor, Muscarinic M4Signal TransductionDyskinesia, Drug-InducedAnimalsMiceParkinson DiseaseAcetylcholineMaleDisease Models, Animal

Substanzen

LevodopaDopamineReceptor, Muscarinic M4Acetylcholine

Autor:innen und Institutionen

  • Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.

ORCID-Profile: Beatriz E Nielsen, Christopher P Ford

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Nielsen, B. E., & Ford, C. P. (2024). Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors. Science Advances, 10(47). https://doi.org/10.1126/sciadv.adp6301

Vancouver

Nielsen BE, Ford CP. Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors. Science Advances. 2024;10(47). doi:10.1126/sciadv.adp6301

BibTeX
@article{Nielsen2024,
  author = {Nielsen, Beatriz E and Ford, Christopher P},
  title = {Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {47},
  doi = {10.1126/sciadv.adp6301}
}
Kostenlos starten →